| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | KIF21B MYH1 MYH6 MYH8 MYH9 CENPE MYO6 MYO9B MYO10 MYH14 DNAH17 DNAH9 KIF11 DNAH11 | 2.18e-13 | 118 | 148 | 14 | GO:0003774 |
| GeneOntologyMolecularFunction | microfilament motor activity | 3.05e-10 | 38 | 148 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | actin filament binding | TPM4 MYH1 MYH6 MYH8 MYH9 MYO6 MYO9B MYO10 SYNE1 CD2AP SHROOM2 MYH14 IQGAP3 FMNL1 | 1.55e-09 | 227 | 148 | 14 | GO:0051015 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPM4 KIF21B MYH1 MYH6 MYH8 SYNPO2 MYH9 CLIP2 CENPE MYO6 MYO9B MYO10 SYNE1 CD2AP TRPC6 DPYSL4 ADGRV1 SHROOM2 DCTN1 MYH14 CGN MTCL1 ARHGEF2 IQGAP3 FMNL1 MX1 MX2 KIF11 | 8.39e-09 | 1099 | 148 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | TPM4 MYH1 MYH6 MYH8 SYNPO2 MYH9 MYO6 MYO9B MYO10 SYNE1 CD2AP TRPC6 SHROOM2 MYH14 CGN IQGAP3 FMNL1 | 1.03e-07 | 479 | 148 | 17 | GO:0003779 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH1 MYH6 MYH8 MYH9 MYO6 MYO9B MYO10 PPP3CB PPP3CC MYH14 PIK3R1 IQGAP3 | 1.50e-07 | 230 | 148 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B MYH1 MYH6 MYH8 MYH9 CENPE MYO6 MYO9B MYO10 AK9 MYH14 RALBP1 DDX18 DNAH17 DNAH9 KIF11 DNAH11 | 3.18e-06 | 614 | 148 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.33e-05 | 70 | 148 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.03e-04 | 308 | 148 | 10 | GO:0008017 | |
| GeneOntologyMolecularFunction | small GTPase binding | DOCK2 RASGRF1 MYO9B ERC1 TNPO2 RALBP1 ARHGEF2 ACAP2 IQGAP3 FMNL1 | 1.44e-04 | 321 | 148 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | cadherin binding | 2.24e-04 | 339 | 148 | 10 | GO:0045296 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.00e-04 | 18 | 148 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | GTPase binding | DOCK2 RASGRF1 MYO9B ERC1 TNPO2 RALBP1 ARHGEF2 ACAP2 IQGAP3 FMNL1 | 3.61e-04 | 360 | 148 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 5.38e-04 | 5 | 148 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | kinetochore binding | 8.03e-04 | 6 | 148 | 2 | GO:0043515 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.14e-03 | 28 | 148 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.36e-03 | 428 | 148 | 10 | GO:0015631 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 1.48e-03 | 8 | 148 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | myosin light chain binding | 1.48e-03 | 8 | 148 | 2 | GO:0032027 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase activity | 1.48e-03 | 8 | 148 | 2 | GO:0004723 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | TPM4 MYH6 SYNPO2 MYH9 EPPK1 CLIP2 MYO6 KRT82 PPFIA1 CD2AP B2M COLGALT2 SHROOM2 CCDC57 DCTN1 ADAMTS12 AKAP9 ADAMTS7 PIK3R1 TPX2 CGNL1 ARHGEF2 IQGAP3 | 2.67e-07 | 957 | 146 | 23 | GO:0097435 |
| GeneOntologyBiologicalProcess | actin filament-based process | DOCK2 TPM4 MYH6 MYH8 SYNPO2 MYH9 MYO6 MYO9B PPFIA1 PCLO CD2AP SHROOM2 AKAP9 MYH14 PIK3R1 CGNL1 ARHGEF2 ACAP2 IQGAP3 FMNL1 | 6.91e-06 | 912 | 146 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | organelle localization | MYH9 CENPE SYNE1 PCLO LMNB2 PPFIA3 SHROOM2 DCTN1 EIF6 LIN7A STXBP1 AKAP9 MAD1L1 VAMP7 ARHGEF2 SLC4A5 | 3.96e-05 | 703 | 146 | 16 | GO:0051640 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | DRC7 MYH9 CLIP2 CENPE CCDC57 DCTN1 AKAP9 INTS13 DNAH17 CGN TPX2 CFAP58 MTCL1 ARHGEF2 KIF11 MYBL2 | 5.26e-05 | 720 | 146 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule-based process | DRC7 KIF21B MYH9 CLIP2 CENPE CCDC57 DCTN1 AKAP9 INTS13 DNAH17 CGN VAMP7 TPX2 CFAP58 MTCL1 ARHGEF2 DNAH9 KIF11 MYBL2 DNAH11 | 5.77e-05 | 1058 | 146 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | cell junction organization | FILIP1 MYH9 MYO6 ERC1 PPFIA1 PCLO CD2AP PPFIA3 SHROOM2 DCTN1 PCDHB16 PTPN11 PLXNC1 NPTXR PIK3R1 CGN EIF4G1 CDH8 HOMER1 | 5.93e-05 | 974 | 146 | 19 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | FILIP1 MYO6 ERC1 PPFIA1 PCLO CD2AP PPFIA3 DCTN1 PCDHB16 PLXNC1 NPTXR PIK3R1 EIF4G1 CDH8 HOMER1 | 1.07e-04 | 685 | 146 | 15 | GO:0050808 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.10e-04 | 153 | 146 | 7 | GO:0030048 | |
| GeneOntologyBiologicalProcess | establishment of organelle localization | MYH9 CENPE SYNE1 PCLO LMNB2 SHROOM2 DCTN1 EIF6 LIN7A STXBP1 MAD1L1 VAMP7 ARHGEF2 | 1.39e-04 | 546 | 146 | 13 | GO:0051656 |
| GeneOntologyCellularComponent | supramolecular fiber | TPM4 KIF21B MYH1 MYH6 MYH8 SYNPO2 MYH9 EPPK1 KRT18 CLIP2 CENPE MYO6 MYO9B KRT82 SYNE1 CD2AP LMNB2 SHROOM2 CCDC57 DCTN1 EIF6 PPP3CB MYH14 DNAH17 TPX2 MTCL1 ARHGEF2 DNAH9 HOMER1 MX1 MX2 KIF11 DNAH11 | 5.05e-12 | 1179 | 146 | 33 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | TPM4 KIF21B MYH1 MYH6 MYH8 SYNPO2 MYH9 EPPK1 KRT18 CLIP2 CENPE MYO6 MYO9B KRT82 SYNE1 CD2AP LMNB2 SHROOM2 CCDC57 DCTN1 EIF6 PPP3CB MYH14 DNAH17 TPX2 MTCL1 ARHGEF2 DNAH9 HOMER1 MX1 MX2 KIF11 DNAH11 | 6.06e-12 | 1187 | 146 | 33 | GO:0099081 |
| GeneOntologyCellularComponent | myosin complex | 9.49e-12 | 59 | 146 | 10 | GO:0016459 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | TPM4 KIF21B MYH9 EPPK1 KRT18 CLIP2 CENPE MYO6 MYO9B KRT82 CD2AP LMNB2 SHROOM2 CCDC57 DCTN1 EIF6 DNAH17 TPX2 MTCL1 ARHGEF2 DNAH9 MX1 MX2 KIF11 DNAH11 | 3.26e-09 | 899 | 146 | 25 | GO:0099513 |
| GeneOntologyCellularComponent | cell cortex | TPM4 MYH9 CLIP2 MYO6 MYO9B MYO10 ERC1 PCLO CD2AP PPFIA3 SHROOM2 DCTN1 STXBP1 IQGAP3 FMNL1 | 5.31e-08 | 371 | 146 | 15 | GO:0005938 |
| GeneOntologyCellularComponent | actin cytoskeleton | TPM4 FILIP1 MYH1 MYH6 MYH8 SYNPO2 MYH9 MYO6 MYO9B MYO10 CD2AP SHROOM2 PTPN11 MYH14 CGN CGNL1 ARHGEF2 | 5.95e-07 | 576 | 146 | 17 | GO:0015629 |
| GeneOntologyCellularComponent | myosin filament | 7.37e-07 | 25 | 146 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.34e-06 | 28 | 146 | 5 | GO:0016460 | |
| GeneOntologyCellularComponent | microtubule | KIF21B CLIP2 CENPE SHROOM2 CCDC57 DCTN1 DNAH17 TPX2 MTCL1 ARHGEF2 DNAH9 MX1 MX2 KIF11 DNAH11 | 5.08e-06 | 533 | 146 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | cell cortex region | 1.51e-05 | 45 | 146 | 5 | GO:0099738 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 1.82e-05 | 23 | 146 | 4 | GO:0098831 | |
| GeneOntologyCellularComponent | anchoring junction | TPM4 MYH1 SYNPO2 MYH9 EPPK1 KRT18 PPFIA1 CD2AP B2M TRPC6 SHROOM2 LIN7A PIK3R1 CGN MME CGNL1 ARHGEF2 CDH8 IQGAP3 | 5.10e-05 | 976 | 146 | 19 | GO:0070161 |
| GeneOntologyCellularComponent | glutamatergic synapse | KIF21B FILIP1 MYO6 ERC1 PCLO ANO1 PPFIA3 STXBP1 PPP3CB PPP3CC AKAP9 PLXNC1 NPTXR ARHGEF2 CDH8 HOMER1 TPD52 | 5.81e-05 | 817 | 146 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | cell-cell junction | MYH1 MYH9 EPPK1 KRT18 CD2AP TRPC6 SHROOM2 LIN7A PIK3R1 CGN CGNL1 ARHGEF2 CDH8 IQGAP3 | 7.02e-05 | 591 | 146 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.06e-04 | 107 | 146 | 6 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.06e-04 | 107 | 146 | 6 | GO:0001725 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.40e-04 | 161 | 146 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | myosin II filament | 1.45e-04 | 3 | 146 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | actomyosin | 1.73e-04 | 117 | 146 | 6 | GO:0042641 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.75e-04 | 16 | 146 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | actin filament bundle | 1.82e-04 | 118 | 146 | 6 | GO:0032432 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 2.98e-04 | 19 | 146 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | bicellular tight junction | 3.20e-04 | 131 | 146 | 6 | GO:0005923 | |
| GeneOntologyCellularComponent | sarcomere | 3.72e-04 | 249 | 146 | 8 | GO:0030017 | |
| GeneOntologyCellularComponent | endocytic vesicle | MYH9 MYO6 CD2AP B2M HEATR5A STXBP1 PIK3C2B VAMP7 VAMP4 FMNL1 | 3.77e-04 | 384 | 146 | 10 | GO:0030139 |
| GeneOntologyCellularComponent | tight junction | 4.39e-04 | 139 | 146 | 6 | GO:0070160 | |
| GeneOntologyCellularComponent | axon | KIF21B RASGRF1 MYO6 PPFIA1 PCLO CD2AP HMBS DCTN1 TNFRSF21 STXBP1 MYH14 NPTXR TPX2 MME CDH8 HOMER1 | 5.07e-04 | 891 | 146 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | intercellular bridge | 5.17e-04 | 94 | 146 | 5 | GO:0045171 | |
| GeneOntologyCellularComponent | dynein complex | 5.51e-04 | 54 | 146 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | nuclear envelope | CALR3 MYO6 SYNE1 CD2AP AK9 LMNB2 DCTN1 MAD1L1 TMPO NUP160 MX1 MX2 | 5.77e-04 | 560 | 146 | 12 | GO:0005635 |
| GeneOntologyCellularComponent | ruffle | 6.23e-04 | 206 | 146 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | myofibril | 6.82e-04 | 273 | 146 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | lamin filament | 7.13e-04 | 6 | 146 | 2 | GO:0005638 | |
| GeneOntologyCellularComponent | calcineurin complex | 7.13e-04 | 6 | 146 | 2 | GO:0005955 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 7.71e-04 | 26 | 146 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 8.33e-04 | 157 | 146 | 6 | GO:0045335 | |
| GeneOntologyCellularComponent | apical junction complex | 8.61e-04 | 158 | 146 | 6 | GO:0043296 | |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 9.62e-04 | 28 | 146 | 3 | GO:0016327 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.01e-03 | 290 | 146 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 1.32e-03 | 8 | 146 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | cytosolic region | 1.46e-03 | 70 | 146 | 4 | GO:0099522 | |
| GeneOntologyCellularComponent | filopodium | 1.73e-03 | 123 | 146 | 5 | GO:0030175 | |
| GeneOntologyCellularComponent | spindle | MYH9 CENPE CCDC57 DCTN1 RALBP1 MAD1L1 TPX2 MTCL1 ARHGEF2 KIF11 | 1.78e-03 | 471 | 146 | 10 | GO:0005819 |
| GeneOntologyCellularComponent | cortical cytoskeleton | 2.13e-03 | 129 | 146 | 5 | GO:0030863 | |
| GeneOntologyCellularComponent | somatodendritic compartment | KIF21B URI1 RASGRF1 CLIP2 MYO6 MYO10 SYNE1 PPFIA1 PCLO CD2AP SHROOM2 DCTN1 AKAP9 NPTXR TPX2 MME ARHGEF2 HOMER1 | 2.31e-03 | 1228 | 146 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | filtration diaphragm | 2.56e-03 | 11 | 146 | 2 | GO:0036056 | |
| GeneOntologyCellularComponent | slit diaphragm | 2.56e-03 | 11 | 146 | 2 | GO:0036057 | |
| GeneOntologyCellularComponent | cell leading edge | MYH9 MYO6 MYO9B MYO10 CD2AP ADGRV1 DCTN1 VAMP7 ARHGEF2 ACAP2 | 2.74e-03 | 500 | 146 | 10 | GO:0031252 |
| GeneOntologyCellularComponent | podosome | 2.93e-03 | 41 | 146 | 3 | GO:0002102 | |
| GeneOntologyCellularComponent | outer dynein arm | 3.05e-03 | 12 | 146 | 2 | GO:0036157 | |
| GeneOntologyCellularComponent | spindle microtubule | 3.11e-03 | 86 | 146 | 4 | GO:0005876 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.14e-03 | 141 | 146 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | spindle pole | 3.22e-03 | 205 | 146 | 6 | GO:0000922 | |
| GeneOntologyCellularComponent | actin filament | 3.64e-03 | 146 | 146 | 5 | GO:0005884 | |
| GeneOntologyCellularComponent | cytoplasmic region | 3.86e-03 | 360 | 146 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | presynaptic cytoskeleton | 4.17e-03 | 14 | 146 | 2 | GO:0099569 | |
| GeneOntologyCellularComponent | brush border | 4.32e-03 | 152 | 146 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 4.85e-03 | 223 | 146 | 6 | GO:0098862 | |
| GeneOntologyCellularComponent | presynaptic cytosol | 4.86e-03 | 49 | 146 | 3 | GO:0099523 | |
| GeneOntologyCellularComponent | nuclear pore | 5.52e-03 | 101 | 146 | 4 | GO:0005643 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | KRT18 MYO6 MYO9B SYNE1 PCLO CD2AP HMBS ADGRV1 THBS3 STXBP1 PIK3R1 VAMP7 MX1 TPD52 | 5.86e-03 | 934 | 146 | 14 | GO:0048471 |
| GeneOntologyCellularComponent | condensed chromosome | 5.89e-03 | 307 | 146 | 7 | GO:0000793 | |
| GeneOntologyCellularComponent | nuclear lamina | 6.15e-03 | 17 | 146 | 2 | GO:0005652 | |
| GeneOntologyCellularComponent | RNA cap binding complex | 6.15e-03 | 17 | 146 | 2 | GO:0034518 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 6.61e-03 | 238 | 146 | 6 | GO:0097729 | |
| GeneOntologyCellularComponent | excitatory synapse | 6.76e-03 | 107 | 146 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | dendrite | KIF21B URI1 RASGRF1 CLIP2 SYNE1 PPFIA1 PCLO CD2AP AKAP9 NPTXR MME ARHGEF2 HOMER1 | 7.20e-03 | 858 | 146 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | KIF21B URI1 RASGRF1 CLIP2 SYNE1 PPFIA1 PCLO CD2AP AKAP9 NPTXR MME ARHGEF2 HOMER1 | 7.33e-03 | 860 | 146 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | growth cone | 7.58e-03 | 245 | 146 | 6 | GO:0030426 | |
| GeneOntologyCellularComponent | filopodium tip | 8.48e-03 | 20 | 146 | 2 | GO:0032433 | |
| GeneOntologyCellularComponent | site of polarized growth | 8.80e-03 | 253 | 146 | 6 | GO:0030427 | |
| GeneOntologyCellularComponent | kinetochore | 8.91e-03 | 181 | 146 | 5 | GO:0000776 | |
| Domain | Myosin_tail_1 | 4.57e-11 | 18 | 146 | 7 | PF01576 | |
| Domain | Myosin_tail | 4.57e-11 | 18 | 146 | 7 | IPR002928 | |
| Domain | IQ | 1.92e-10 | 71 | 146 | 10 | PF00612 | |
| Domain | Myosin_head_motor_dom | 4.61e-10 | 38 | 146 | 8 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 4.61e-10 | 38 | 146 | 8 | PS51456 | |
| Domain | Myosin_head | 4.61e-10 | 38 | 146 | 8 | PF00063 | |
| Domain | MYSc | 4.61e-10 | 38 | 146 | 8 | SM00242 | |
| Domain | IQ | 7.30e-10 | 81 | 146 | 10 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 2.10e-09 | 90 | 146 | 10 | IPR000048 | |
| Domain | IQ | 2.90e-09 | 93 | 146 | 10 | PS50096 | |
| Domain | Myosin_N | 7.68e-08 | 15 | 146 | 5 | PF02736 | |
| Domain | Myosin_N | 7.68e-08 | 15 | 146 | 5 | IPR004009 | |
| Domain | Myosin-like_IQ_dom | 2.90e-07 | 19 | 146 | 5 | IPR027401 | |
| Domain | - | 2.90e-07 | 19 | 146 | 5 | 4.10.270.10 | |
| Domain | GOLGA6L | 9.20e-06 | 6 | 146 | 3 | IPR026737 | |
| Domain | P-loop_NTPase | KIF21B MYH1 MYH6 MYH8 MYH9 CENPE MYO6 MYO9B MYO10 MTHFD1L AK9 SBNO2 MYH14 DDX18 DNAH9 MX1 MX2 KIF11 DNAH11 | 3.47e-05 | 848 | 146 | 19 | IPR027417 |
| Domain | ARM-type_fold | DOCK2 TNPO2 NCBP1 HEATR5A HEATR1 VIRMA PIK3C2B EIF4G1 TTI1 GCN1 FMNL1 | 7.41e-05 | 339 | 146 | 11 | IPR016024 |
| Domain | GOLGA2L5 | 3.50e-04 | 18 | 146 | 3 | PF15070 | |
| Domain | Golgin_A | 3.50e-04 | 18 | 146 | 3 | IPR024858 | |
| Domain | Rho_GTPase_activation_prot | 6.34e-04 | 88 | 146 | 5 | IPR008936 | |
| Domain | Dynamin_central | 8.92e-04 | 6 | 146 | 2 | IPR000375 | |
| Domain | GED | 8.92e-04 | 6 | 146 | 2 | SM00302 | |
| Domain | Dynamin_M | 8.92e-04 | 6 | 146 | 2 | PF01031 | |
| Domain | GED_dom | 8.92e-04 | 6 | 146 | 2 | IPR020850 | |
| Domain | GED | 8.92e-04 | 6 | 146 | 2 | PS51388 | |
| Domain | Dynamin_GTPase_CS | 8.92e-04 | 6 | 146 | 2 | IPR019762 | |
| Domain | GED | 8.92e-04 | 6 | 146 | 2 | PF02212 | |
| Domain | GED | 8.92e-04 | 6 | 146 | 2 | IPR003130 | |
| Domain | Liprin | 8.92e-04 | 6 | 146 | 2 | IPR029515 | |
| Domain | Peptidase_M13_C | 1.24e-03 | 7 | 146 | 2 | IPR018497 | |
| Domain | Peptidase_M13 | 1.24e-03 | 7 | 146 | 2 | IPR000718 | |
| Domain | Peptidase_M13_N | 1.24e-03 | 7 | 146 | 2 | PF05649 | |
| Domain | Peptidase_M13_N | 1.24e-03 | 7 | 146 | 2 | IPR008753 | |
| Domain | G_DYNAMIN_1 | 1.24e-03 | 7 | 146 | 2 | PS00410 | |
| Domain | Peptidase_M13 | 1.24e-03 | 7 | 146 | 2 | PF01431 | |
| Domain | DYNc | 1.24e-03 | 7 | 146 | 2 | SM00053 | |
| Domain | Metallophos | 1.33e-03 | 28 | 146 | 3 | PF00149 | |
| Domain | Calcineurin-like_PHP_ApaH | 1.33e-03 | 28 | 146 | 3 | IPR004843 | |
| Domain | Metallo-depent_PP-like | 1.63e-03 | 30 | 146 | 3 | IPR029052 | |
| Domain | - | 1.63e-03 | 30 | 146 | 3 | 3.60.21.10 | |
| Domain | DHC_N1 | 1.65e-03 | 8 | 146 | 2 | PF08385 | |
| Domain | SYNAPTOBREVIN | 1.65e-03 | 8 | 146 | 2 | PS00417 | |
| Domain | - | 1.65e-03 | 8 | 146 | 2 | 1.10.3840.10 | |
| Domain | Dynein_heavy_dom-1 | 1.65e-03 | 8 | 146 | 2 | IPR013594 | |
| Domain | HTH_MYB | 2.11e-03 | 9 | 146 | 2 | PS51294 | |
| Domain | Myb_dom | 2.11e-03 | 9 | 146 | 2 | IPR017930 | |
| Domain | HEAT_REPEAT | 2.20e-03 | 70 | 146 | 4 | PS50077 | |
| Domain | Prefoldin | 2.44e-03 | 72 | 146 | 4 | IPR009053 | |
| Domain | MIF4G | 2.62e-03 | 10 | 146 | 2 | SM00543 | |
| Domain | CAP_GLY | 2.62e-03 | 10 | 146 | 2 | PF01302 | |
| Domain | MIF4G | 2.62e-03 | 10 | 146 | 2 | PF02854 | |
| Domain | CAP_GLY | 2.62e-03 | 10 | 146 | 2 | SM01052 | |
| Domain | - | 2.62e-03 | 10 | 146 | 2 | 2.30.30.190 | |
| Domain | MIF4G-like_typ-3 | 2.62e-03 | 10 | 146 | 2 | IPR003890 | |
| Domain | CAP_GLY_1 | 2.62e-03 | 10 | 146 | 2 | PS00845 | |
| Domain | CAP_GLY_2 | 2.62e-03 | 10 | 146 | 2 | PS50245 | |
| Domain | CAP-Gly_domain | 2.62e-03 | 10 | 146 | 2 | IPR000938 | |
| Domain | Synaptobrevin | 3.19e-03 | 11 | 146 | 2 | PF00957 | |
| Domain | GDS_CDC24_CS | 3.48e-03 | 39 | 146 | 3 | IPR001331 | |
| Domain | - | 3.74e-03 | 81 | 146 | 4 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 3.74e-03 | 81 | 146 | 4 | IPR024079 | |
| Domain | V_SNARE | 3.80e-03 | 12 | 146 | 2 | PS50892 | |
| Domain | Kinesin_motor_CS | 4.01e-03 | 41 | 146 | 3 | IPR019821 | |
| Domain | PP2Ac | 4.47e-03 | 13 | 146 | 2 | SM00156 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 4.47e-03 | 13 | 146 | 2 | IPR006186 | |
| Domain | SER_THR_PHOSPHATASE | 4.47e-03 | 13 | 146 | 2 | PS00125 | |
| Domain | Synaptobrevin | 4.47e-03 | 13 | 146 | 2 | IPR001388 | |
| Domain | Kinesin-like_fam | 4.59e-03 | 43 | 146 | 3 | IPR027640 | |
| Domain | - | 4.90e-03 | 44 | 146 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 4.90e-03 | 44 | 146 | 3 | PF00225 | |
| Domain | KISc | 4.90e-03 | 44 | 146 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.90e-03 | 44 | 146 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.90e-03 | 44 | 146 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.90e-03 | 44 | 146 | 3 | PS50067 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.19e-03 | 14 | 146 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.19e-03 | 14 | 146 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.19e-03 | 14 | 146 | 2 | IPR013602 | |
| Domain | G_DYNAMIN_dom | 5.19e-03 | 14 | 146 | 2 | IPR030381 | |
| Domain | DHC_N2 | 5.19e-03 | 14 | 146 | 2 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 5.19e-03 | 14 | 146 | 2 | IPR011704 | |
| Domain | MT | 5.19e-03 | 14 | 146 | 2 | PF12777 | |
| Domain | AAA_8 | 5.19e-03 | 14 | 146 | 2 | PF12780 | |
| Domain | G_DYNAMIN_2 | 5.19e-03 | 14 | 146 | 2 | PS51718 | |
| Domain | AAA_5 | 5.19e-03 | 14 | 146 | 2 | PF07728 | |
| Domain | DHC_fam | 5.96e-03 | 15 | 146 | 2 | IPR026983 | |
| Domain | Dynamin_GTPase | 5.96e-03 | 15 | 146 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 5.96e-03 | 15 | 146 | 2 | IPR022812 | |
| Domain | - | 5.96e-03 | 15 | 146 | 2 | 1.25.40.180 | |
| Domain | Dynein_heavy | 5.96e-03 | 15 | 146 | 2 | PF03028 | |
| Domain | Dynamin_N | 5.96e-03 | 15 | 146 | 2 | PF00350 | |
| Domain | MIF4-like | 5.96e-03 | 15 | 146 | 2 | IPR016021 | |
| Domain | Dynein_heavy_dom | 5.96e-03 | 15 | 146 | 2 | IPR004273 | |
| Domain | HEAT | 6.26e-03 | 48 | 146 | 3 | PF02985 | |
| Domain | - | 6.58e-03 | 95 | 146 | 4 | 2.60.120.200 | |
| Domain | ZINC_PROTEASE | 7.34e-03 | 98 | 146 | 4 | PS00142 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.11e-05 | 70 | 114 | 6 | M12294 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.19e-05 | 23 | 114 | 4 | MM14852 | |
| Pathway | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.19e-05 | 23 | 114 | 4 | M12627 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 6.17e-05 | 27 | 114 | 4 | M47755 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK2 TPM4 FILIP1 MYH9 CENPE MYO6 MYO9B MYH14 PIK3R1 RALBP1 MAD1L1 TMPO ARHGEF3 ARHGEF2 IQGAP3 NUP160 FMNL1 | 6.44e-05 | 720 | 114 | 17 | M41838 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK2 TPM4 FILIP1 MYH9 CENPE MYO6 MYO9B MYH14 PIK3R1 RALBP1 MAD1L1 ARHGEF3 ARHGEF2 IQGAP3 NUP160 FMNL1 | 6.51e-05 | 649 | 114 | 16 | MM15690 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 2.05e-04 | 149 | 114 | 7 | M41805 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.36e-04 | 69 | 114 | 5 | MM15596 | |
| Pathway | PID_RAC1_REG_PATHWAY | 2.42e-04 | 38 | 114 | 4 | M241 | |
| Pathway | REACTOME_RHOB_GTPASE_CYCLE | 2.52e-04 | 70 | 114 | 5 | M41806 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK2 TPM4 FILIP1 MYO6 MYO9B PIK3R1 RALBP1 TMPO ARHGEF3 ARHGEF2 IQGAP3 FMNL1 | 2.80e-04 | 450 | 114 | 12 | M27078 |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.22e-04 | 17 | 114 | 3 | M93 | |
| Pathway | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.22e-04 | 17 | 114 | 3 | MM14907 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.85e-04 | 18 | 114 | 3 | M13015 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 3.85e-04 | 18 | 114 | 3 | MM14702 | |
| Pathway | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | 3.85e-04 | 18 | 114 | 3 | MM14703 | |
| Pathway | REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE | 3.85e-04 | 18 | 114 | 3 | M27043 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 3.93e-04 | 43 | 114 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 4.68e-04 | 45 | 114 | 4 | M47670 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 6.90e-04 | 87 | 114 | 5 | M27617 | |
| Pathway | KEGG_TIGHT_JUNCTION | 7.02e-04 | 132 | 114 | 6 | M11355 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 7.32e-04 | 184 | 114 | 7 | M41809 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | MYH9 MYO9B MYO10 TRPC6 DPYSL4 NCBP1 ADGRV1 PTPN11 PPP3CB MYH14 PLXNC1 PIK3R1 EIF4G1 | 7.50e-04 | 575 | 114 | 13 | M29853 |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 7.56e-04 | 51 | 114 | 4 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 7.56e-04 | 51 | 114 | 4 | MM14499 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK2 TPM4 FILIP1 MYO6 MYO9B PIK3R1 RALBP1 ARHGEF3 ARHGEF2 IQGAP3 FMNL1 | 8.50e-04 | 439 | 114 | 11 | MM15595 |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.21e-04 | 24 | 114 | 3 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 9.21e-04 | 24 | 114 | 3 | M630 | |
| Pubmed | TPM4 MYH1 MYH6 MYH8 MYH9 KRT18 PDHB ERC1 SYNE1 PPFIA1 PCLO U2SURP UTP14A NCBP1 ZNF318 LMNB2 HEATR1 ZFC3H1 CCDC57 DCTN1 FER1L6 ADAMTS12 RUNDC3A STXBP1 MYH14 EIF4G1 TMPO ARHGEF2 KIF11 NSMCE4A | 6.65e-13 | 1442 | 150 | 30 | 35575683 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPM4 MYH9 EPPK1 KRT18 MYO6 ARGLU1 ERC1 UTP14A MRPL28 NCBP1 LMNB2 HEATR1 ZFC3H1 YTHDC1 VIRMA EIF6 PPP3CB DDX18 CGN EIF4G1 TPX2 TMPO ARHGEF2 IQGAP3 NUP160 KIF11 | 3.21e-11 | 1257 | 150 | 26 | 36526897 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | TPM4 MYH1 MYH6 MYH8 TBC1D15 MYH9 MRI1 EPPK1 KRT18 MYO6 B2M NCBP1 LMNB2 DCTN1 MYH14 TTI1 IQGAP3 MX1 MX2 | 5.87e-11 | 647 | 150 | 19 | 26618866 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TBC1D15 EPPK1 KRT18 MYO9B ARGLU1 KRT82 SYNE1 U2SURP UTP14A NCBP1 ZNF318 LMNB2 HEATR1 EIF6 SMPDL3B MYH14 DDX18 CGN EIF4G1 TMPO ARHGEF2 GCN1 NUP160 | 1.01e-10 | 1024 | 150 | 23 | 24711643 |
| Pubmed | KIF21B MYH9 CLIP2 CENPE ARGLU1 ERC1 SYNE1 PPFIA1 DPYSL4 ZNF318 LMNB2 PPFIA3 DCTN1 VIRMA PPP3CB AKAP9 MAD1L1 EIF4G1 MTCL1 ARHGEF2 HOMER1 KIF11 | 1.96e-10 | 963 | 150 | 22 | 28671696 | |
| Pubmed | ANKRD35 MYH9 KRT18 MYO6 PDHB MYO9B ARGLU1 U2SURP UTP14A NCBP1 YTHDC1 DCTN1 EIF6 EAF1 SMPDL3B AKAP9 MYH14 PIK3R1 DDX18 CGN EIF4G1 TMPO ARHGEF2 GCN1 | 8.48e-10 | 1247 | 150 | 24 | 27684187 | |
| Pubmed | MYH9 EPPK1 MTHFD1L U2SURP UTP14A NCBP1 ZNF318 LMNB2 HEATR1 VIRMA EIF6 MYH14 DDX18 CGN EIF4G1 GCN1 NUP160 | 3.89e-09 | 653 | 150 | 17 | 22586326 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DOCK2 MYH9 EPPK1 ARGLU1 PPFIA1 U2SURP NCBP1 DCTN1 INTS13 MAD1L1 TPX2 TMPO MTCL1 ARHGEF2 GCN1 KIF11 | 5.36e-09 | 582 | 150 | 16 | 20467437 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPE PDHB MYO9B UTP14A NCBP1 HEATR1 ZFC3H1 VIRMA EIF6 DDX18 EIF4G1 TPX2 TMPO ARHGEF2 GCN1 IQGAP3 WDR24 NSMCE4A | 5.62e-09 | 759 | 150 | 18 | 35915203 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | ANKRD35 RASGRF1 CENPE ERC1 ZFC3H1 YTHDC1 EIF4G1 TMPO MTCL1 DNAH9 FMNL1 KIF11 WDR24 | 6.67e-09 | 361 | 150 | 13 | 26167880 |
| Pubmed | DOCK2 MYH9 CENPE MYO6 MYO9B MTHFD1L B2M RFFL HEATR1 DCTN1 EHBP1L1 CSGALNACT2 MYH14 PLXNC1 PIK3R1 DDX18 EIF4G1 TMPO ACAP2 GCN1 FMNL1 KIF11 | 6.83e-09 | 1168 | 150 | 22 | 19946888 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | MRI1 EPPK1 PDHB MTHFD1L U2SURP NCBP1 LMNB2 DCTN1 VIRMA PTPN11 MYH14 AASS DDX18 EIF4G1 GCN1 NUP160 | 9.66e-09 | 607 | 150 | 16 | 39147351 |
| Pubmed | TPM4 MYH6 MYH9 CLIP2 MYO6 PDHB ARGLU1 ERC1 SYNE1 PPFIA1 PCLO DPYSL4 PPFIA3 SHROOM2 DCTN1 VIRMA STXBP1 MYH14 EIF4G1 TMPO CGNL1 ARHGEF2 HOMER1 DNAH11 | 1.23e-08 | 1431 | 150 | 24 | 37142655 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPPK1 MYO9B MYO10 MTHFD1L LMNB2 DCTN1 TNFRSF21 EIF6 SBNO2 CCDC142 EHBP1L1 ADAMTS7 PIK3C2B TMCC2 MAD1L1 EIF4G1 ARHGEF2 GCN1 IQGAP3 WDR24 MYBL2 | 1.34e-08 | 1105 | 150 | 21 | 35748872 |
| Pubmed | 1.68e-08 | 147 | 150 | 9 | 16959763 | ||
| Pubmed | EPPK1 CENPE UTP14A YTHDC1 MAD1L1 TPX2 MTCL1 ARHGEF2 NUP160 KIF11 | 2.92e-08 | 210 | 150 | 10 | 16565220 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TBC1D15 MYH9 MYO6 PDHB MTHFD1L SYNE1 PCLO U2SURP UTP14A NCBP1 LMNB2 HEATR1 DCTN1 EIF6 PTPN11 MYH14 DDX18 EIF4G1 TMPO GCN1 IQGAP3 NUP160 KIF11 | 5.15e-08 | 1425 | 150 | 23 | 30948266 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPM4 TBC1D15 MYH9 KRT18 PDHB PPFIA1 CD2AP NCBP1 DPP8 EIF6 PTPN11 EHBP1L1 PPP3CB MYH14 INTS13 ASMTL MAD1L1 EIF4G1 TTI1 GCN1 KYNU NUP160 TPD52 | 7.48e-08 | 1455 | 150 | 23 | 22863883 |
| Pubmed | 8.06e-08 | 234 | 150 | 10 | 36243803 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPM4 MYH9 KRT18 MYO6 ERC1 U2SURP UTP14A DPYSL4 ZNF318 HEATR1 DCTN1 EIF6 PTPN11 TPX2 TMPO CGNL1 GCN1 KIF11 | 1.29e-07 | 934 | 150 | 18 | 33916271 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPM4 MYH9 EPPK1 KRT18 MYO6 ARGLU1 MYO10 SYNE1 U2SURP UTP14A HEATR1 YTHDC1 DCTN1 MYH14 DDX18 TPX2 ARHGEF2 DUSP11 | 1.63e-07 | 949 | 150 | 18 | 36574265 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.86e-07 | 256 | 150 | 10 | 33397691 | |
| Pubmed | TBC1D15 MYH9 EPPK1 ERC1 MTHFD1L SYNE1 LMNB2 HEATR1 PPFIA3 DCTN1 EIF6 DDX18 EIF4G1 TPX2 ACAP2 NUP160 | 1.88e-07 | 754 | 150 | 16 | 35906200 | |
| Pubmed | DRC7 TBC1D15 MYH9 ERC1 CD2AP LMNB2 PTPN11 EIF4G1 VAMP7 TMPO VAMP4 GCN1 FMNL1 TPD52 | 1.92e-07 | 568 | 150 | 14 | 37774976 | |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 2.08e-07 | 197 | 150 | 9 | 20811636 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KRT18 ERC1 PPFIA1 CD2AP DPP8 VIRMA FAM117A AKAP9 PIK3C2B AASS CGN MAD1L1 EIF4G1 MTCL1 CGNL1 ARHGEF2 KIF11 | 2.11e-07 | 861 | 150 | 17 | 36931259 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | TPM4 MYH9 PDHB ARGLU1 SYNE1 U2SURP UTP14A DPYSL4 NCBP1 LMNB2 YTHDC1 LIN7A EHBP1L1 DDX18 EIF4G1 TMPO ARHGEF2 GCN1 COG4 | 2.35e-07 | 1082 | 150 | 19 | 38697112 |
| Pubmed | TPM4 MYH9 MYO6 PDHB U2SURP UTP14A LMNB2 MYH14 CGN TMPO NUP160 | 2.47e-07 | 334 | 150 | 11 | 30425250 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 2.58e-07 | 202 | 150 | 9 | 33005030 | |
| Pubmed | 2.58e-07 | 202 | 150 | 9 | 24639526 | ||
| Pubmed | Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner ear. | 3.14e-07 | 4 | 150 | 3 | 15079858 | |
| Pubmed | 3.22e-07 | 14 | 150 | 4 | 8022818 | ||
| Pubmed | 3.44e-07 | 152 | 150 | 8 | 34299191 | ||
| Pubmed | 4.53e-07 | 216 | 150 | 9 | 31519766 | ||
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | TPM4 MYH9 GCFC2 CLIP2 MYO6 ERC1 PPFIA1 DCTN1 NT5C AASS INTS13 MAD1L1 EIF4G1 ARHGEF3 ACAP2 KIF11 TEDC1 | 5.70e-07 | 925 | 150 | 17 | 28986522 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPM4 MYH9 EPPK1 KRT18 MYO6 PDHB ERC1 TNPO2 U2SURP CD2AP DCTN1 EIF6 EIF4G1 TMPO GCN1 IQGAP3 HOMER1 KIF11 TPD52 | 5.82e-07 | 1149 | 150 | 19 | 35446349 |
| Pubmed | URI1 KRT18 PDHB ERC1 PPFIA1 NCBP1 PPFIA3 PTPN11 PPP3CB PPP3CC AKAP9 PIK3R1 CGN TMPO TTI1 ARHGEF2 GCN1 TPD52 | 6.97e-07 | 1049 | 150 | 18 | 27880917 | |
| Pubmed | MYO6 MRPL28 COLGALT2 PPFIA3 VIRMA FER1L6 EHBP1L1 STXBP1 AASS INTS13 MTCL1 ARHGEF2 MYBL2 DNAH11 | 7.71e-07 | 638 | 150 | 14 | 31182584 | |
| Pubmed | MYH9 KRT18 CLIP2 U2SURP B2M MRPL28 NCBP1 HEATR1 ZFC3H1 YTHDC1 DCTN1 EIF6 MYH14 DDX18 EIF4G1 TPX2 | 8.76e-07 | 847 | 150 | 16 | 35850772 | |
| Pubmed | 1.13e-06 | 312 | 150 | 10 | 37120454 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MYH9 KRT18 MYO6 ARGLU1 ERC1 CD2AP EHBP1L1 CGN EIF4G1 PALM3 TMPO GCN1 TPD52 | 1.15e-06 | 565 | 150 | 13 | 25468996 |
| Pubmed | TPM4 SYNPO2 MYH9 KRT18 CLIP2 MYO6 SYNE1 DCTN1 PIK3R1 CGNL1 GCN1 COG4 | 1.46e-06 | 486 | 150 | 12 | 20936779 | |
| Pubmed | 1.53e-06 | 20 | 150 | 4 | 23791195 | ||
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 14718566 | ||
| Pubmed | TBC1D15 PDHB U2SURP UTP14A NCBP1 YTHDC1 EIF6 EHBP1L1 EIF4G1 TPX2 TPD52 | 1.56e-06 | 403 | 150 | 11 | 35253629 | |
| Pubmed | 1.65e-06 | 187 | 150 | 8 | 26460568 | ||
| Pubmed | The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability. | 1.77e-06 | 328 | 150 | 10 | 23398456 | |
| Pubmed | MYH9 EPPK1 MYO9B MYO10 CAMK2N2 DCTN1 EIF4G1 MTCL1 ARHGEF2 SLC4A5 | 1.97e-06 | 332 | 150 | 10 | 37433992 | |
| Pubmed | TPM4 MYH9 CLIP2 MYO6 PPFIA1 NCBP1 VIRMA EIF6 AKAP9 MYH14 RALBP1 DDX18 CGN EIF4G1 TPX2 TMPO ARHGEF2 GCN1 MX2 DUSP11 | 1.98e-06 | 1371 | 150 | 20 | 36244648 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 2.39e-06 | 264 | 150 | 9 | 32814769 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | DOCK2 MYH9 EPPK1 ERC1 SYNE1 PCLO NCBP1 EIF6 AKAP9 MYH14 DDX18 EIF4G1 GCN1 KYNU IQGAP3 | 2.39e-06 | 807 | 150 | 15 | 30575818 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | MRI1 EPPK1 MYO6 PDHB MTHFD1L HEATR1 DCTN1 VIRMA EIF6 STXBP1 GCN1 IQGAP3 NUP160 KIF11 | 2.43e-06 | 704 | 150 | 14 | 29955894 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | CENPE SYNE1 U2SURP CD2AP DCTN1 TUFT1 TRIM69 MAD1L1 EIF4G1 TPX2 TMPO MTCL1 GCN1 IQGAP3 NUP160 HOMER1 NSMCE4A MYBL2 | 2.71e-06 | 1155 | 150 | 18 | 20360068 |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 11212352 | ||
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 16819597 | ||
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 31178125 | ||
| Pubmed | CLIP2 MYO6 PDHB ARGLU1 ERC1 TNPO2 SYNE1 NCBP1 ZFC3H1 SHROOM2 DCTN1 STXBP1 PPP3CB MYH14 PIK3R1 RALBP1 DDX18 EIF4G1 COG4 | 3.01e-06 | 1285 | 150 | 19 | 35914814 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPM4 MYH9 URI1 EPPK1 KRT18 ERC1 MTHFD1L U2SURP UTP14A MRPL28 NCBP1 DCTN1 EIF6 PTPN11 DDX18 EIF4G1 MTCL1 ARHGEF2 GCN1 KIF11 | 3.19e-06 | 1415 | 150 | 20 | 28515276 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | TPM4 MYH9 MYO6 UTP14A ZNF318 LMNB2 HEATR1 EIF6 MYH14 DDX18 MAD1L1 ARHGEF2 NUP160 | 3.42e-06 | 624 | 150 | 13 | 33729478 |
| Pubmed | 4.04e-06 | 360 | 150 | 10 | 33111431 | ||
| Pubmed | DOCK2 TPM4 MYH1 MYH6 MYH8 MYH9 EPPK1 KRT18 MYO9B SYNE1 ZNF318 HEATR1 MYH14 EIF4G1 GCN1 | 4.11e-06 | 844 | 150 | 15 | 25963833 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 4.14e-06 | 361 | 150 | 10 | 30344098 | |
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 3864153 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | URI1 PDHB ERC1 HEATR1 DPP8 DCTN1 MMADHC TUFT1 FAM117A EAF1 PIK3R1 CGN VAMP7 TTI1 ACAP2 GCN1 IQGAP3 NUP160 WDR24 | 4.48e-06 | 1321 | 150 | 19 | 27173435 |
| Pubmed | MYH9 MYO6 MTHFD1L U2SURP HEATR1 YTHDC1 EIF6 DDX18 EIF4G1 TMPO GCN1 SLC4A5 NUP160 | 4.58e-06 | 641 | 150 | 13 | 36057605 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 4.98e-06 | 289 | 150 | 9 | 23752268 | |
| Pubmed | TBC1D15 ERC1 CD2AP ZNF318 HEATR1 DCTN1 PTPN11 CGN TPX2 TMPO GCN1 TPD52 | 5.10e-06 | 549 | 150 | 12 | 38280479 | |
| Pubmed | MYH9 EPPK1 KRT18 PDHB ERC1 SYNE1 DDX18 TPX2 TMPO GCN1 NUP160 | 5.86e-06 | 463 | 150 | 11 | 34901782 | |
| Pubmed | TBC1D15 MYO6 PDHB MTHFD1L TNPO2 MRPL28 INTS13 EIF4G1 TPX2 TMPO NUP160 KIF11 | 6.23e-06 | 560 | 150 | 12 | 35241646 | |
| Pubmed | KIF21B MYH9 KRT18 MYO6 U2SURP NCBP1 LMNB2 HEATR1 EIF6 DDX18 EIF4G1 TMPO NUP160 | 6.26e-06 | 660 | 150 | 13 | 32780723 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH9 KRT18 MYO6 PDHB MYO9B MTHFD1L U2SURP UTP14A LMNB2 HEATR1 DCTN1 EIF6 MYH14 DDX18 EIF4G1 ARHGEF2 GCN1 NUP160 KIF11 | 6.30e-06 | 1353 | 150 | 19 | 29467282 |
| Pubmed | 6.48e-06 | 9 | 150 | 3 | 12923177 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TPM4 TBC1D15 CENPE MYO6 PDHB ARGLU1 MTHFD1L SYNE1 PCLO UTP14A MRPL28 LMNB2 HEATR1 AKAP9 AASS PIK3R1 DDX18 TMPO ARHGEF2 NUP160 | 7.27e-06 | 1496 | 150 | 20 | 32877691 |
| Pubmed | ARGLU1 MTHFD1L SYNE1 PPFIA1 CD2AP UTP14A ZNF318 HEATR1 ZFC3H1 YTHDC1 VIRMA EIF6 PPP3CC INTS13 EIF4G1 TPX2 PALM3 ARHGEF2 IQGAP3 DUSP11 | 7.35e-06 | 1497 | 150 | 20 | 31527615 | |
| Pubmed | Neurotransmitter release regulated by a MALS-liprin-alpha presynaptic complex. | 8.35e-06 | 30 | 150 | 4 | 16186258 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 8.90e-06 | 394 | 150 | 10 | 27248496 | |
| Pubmed | 9.55e-06 | 31 | 150 | 4 | 15217342 | ||
| Pubmed | DOCK2 CLIP2 MYO6 UTP14A ZFC3H1 YTHDC1 TMCC2 DNAH17 CGN CGNL1 NUP160 | 1.05e-05 | 493 | 150 | 11 | 15368895 | |
| Pubmed | DOCK2 EPPK1 CD2AP MRPL28 LMNB2 HEATR1 VIRMA EIF6 PIK3R1 RALBP1 CGN TPX2 ARHGEF3 ARHGEF2 GCN1 | 1.09e-05 | 916 | 150 | 15 | 32203420 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B CENPE MYO6 MTHFD1L PPFIA1 U2SURP AK9 CCDC57 PIK3C2B TMPO HOMER1 | 1.14e-05 | 497 | 150 | 11 | 36774506 |
| Pubmed | Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. | 1.26e-05 | 11 | 150 | 3 | 20351715 | |
| Pubmed | 1.29e-05 | 118 | 150 | 6 | 30979931 | ||
| Pubmed | Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. | 1.34e-05 | 327 | 150 | 9 | 15592455 | |
| Pubmed | 1.39e-05 | 250 | 150 | 8 | 33536335 | ||
| Pubmed | A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. | 1.39e-05 | 34 | 150 | 4 | 12577067 | |
| Pubmed | TBC1D15 MYH9 ERC1 PPFIA1 CD2AP ZNF318 DCTN1 GCN1 KIF11 MYBL2 | 1.48e-05 | 418 | 150 | 10 | 34709266 | |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PDHB MCFD2 SYNE1 PPFIA1 B2M NCBP1 RFFL EHBP1L1 VAMP7 ACAP2 NUP160 KIF11 TPD52 | 1.55e-05 | 719 | 150 | 13 | 35337019 |
| Pubmed | 1.68e-05 | 12 | 150 | 3 | 8424456 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | KIF21B MYH6 MYO6 PDHB ERC1 PCLO LMNB2 PPFIA3 DCTN1 STXBP1 ARHGEF2 HOMER1 | 1.74e-05 | 621 | 150 | 12 | 22794259 |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25385598 | ||
| Pubmed | Oligomerization Requirements for MX2-Mediated Suppression of HIV-1 Infection. | 1.85e-05 | 2 | 150 | 2 | 26446602 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16156639 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 11593409 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29191928 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25363729 | ||
| Pubmed | Genomic organization of the DCTN1-SLC4A5 locus encoding both NBC4 and p150(Glued). | 1.85e-05 | 2 | 150 | 2 | 12063394 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 12024020 | ||
| Pubmed | TPX2 regulates the localization and activity of Eg5 in the mammalian mitotic spindle. | 1.85e-05 | 2 | 150 | 2 | 21969468 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 11340157 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 30479371 | ||
| Interaction | KIF23 interactions | OTOA MYH9 EPPK1 PDHB MYO9B ARGLU1 ERC1 TNPO2 PCLO CD2AP UTP14A NCBP1 AK9 LMNB2 HEATR1 ZFC3H1 TNFRSF21 VIRMA EIF6 MYH14 PIK3R1 DDX18 EIF4G1 TMPO MTCL1 MME ARHGEF2 GCN1 IQGAP3 KIF11 | 7.56e-11 | 1031 | 148 | 30 | int:KIF23 |
| Interaction | CIT interactions | TPM4 ANKRD35 MYH9 EPPK1 MYO6 PDHB MYO9B ARGLU1 ERC1 TNPO2 SYNE1 PCLO UTP14A MRPL28 NCBP1 HEATR5A LMNB2 HEATR1 ADGRV1 DCTN1 VIRMA EIF6 AKAP9 MYH14 DDX18 EIF4G1 TPX2 TMPO ARHGEF2 GCN1 NUP160 HOMER1 KIF11 | 4.04e-09 | 1450 | 148 | 33 | int:CIT |
| Interaction | PRC1 interactions | DOCK2 OTOA ANKRD35 MYH9 EPPK1 CENPE PDHB ARGLU1 SYNE1 NCBP1 LMNB2 HEATR1 YTHDC1 DCTN1 VIRMA EIF6 AKAP9 DDX18 TPX2 TMPO MTCL1 GCN1 IQGAP3 NUP160 | 1.74e-07 | 973 | 148 | 24 | int:PRC1 |
| Interaction | SNRK interactions | 1.93e-07 | 35 | 148 | 6 | int:SNRK | |
| Interaction | ITSN1 interactions | CLIP2 MYO6 SYNE1 ZFC3H1 VIRMA RUNDC3A PTPN11 PIK3C2B MYH14 PIK3R1 RALBP1 COG4 | 4.89e-07 | 259 | 148 | 12 | int:ITSN1 |
| Interaction | RHOA interactions | SYNPO2 EPPK1 RASGRF1 MYO6 PDHB MYO9B PPFIA1 B2M AK9 LMNB2 HEATR1 YTHDC1 VIRMA PTPN11 CSGALNACT2 PIK3R1 DDX18 VAMP7 TMPO ARHGEF3 ARHGEF2 GCN1 IQGAP3 FMNL1 MX2 TPD52 | 6.05e-07 | 1199 | 148 | 26 | int:RHOA |
| Interaction | MAPRE1 interactions | TPM4 CLIP2 CENPE MYO10 ERC1 CD2AP UTP14A LMNB2 DCTN1 AKAP9 RALBP1 DDX18 EIF4G1 ARHGEF2 NUP160 KIF11 | 1.25e-06 | 514 | 148 | 16 | int:MAPRE1 |
| Interaction | SRPK2 interactions | ANKRD35 RASGRF1 ARGLU1 ERC1 U2SURP NCBP1 ZFC3H1 YTHDC1 VIRMA DDX18 EIF4G1 TMPO MTCL1 DNAH9 FMNL1 KIF11 WDR24 TPD52 NSMCE4A | 1.34e-06 | 717 | 148 | 19 | int:SRPK2 |
| Interaction | KIF20A interactions | TPM4 OTOA ANKRD35 MYH9 EPPK1 CENPE MYO6 ARGLU1 MCFD2 SYNE1 PCLO NCBP1 ZNF318 LMNB2 HEATR1 DCTN1 VIRMA MYH14 DDX18 CGN TPX2 TMPO GCN1 | 2.57e-06 | 1052 | 148 | 23 | int:KIF20A |
| Interaction | YWHAB interactions | KIF21B URI1 KRT18 RASGRF1 CENPE ERC1 PPFIA1 DPP8 DCTN1 VIRMA EIF6 PTPN11 FAM117A AKAP9 PIK3C2B AASS CGN EIF4G1 MTCL1 CGNL1 ARHGEF2 HOMER1 | 4.94e-06 | 1014 | 148 | 22 | int:YWHAB |
| Interaction | PHLPP1 interactions | MYH9 EPPK1 KRT18 PDHB CD2AP ZNF318 HEATR1 VIRMA EIF4G1 TPX2 GCN1 KIF11 | 6.66e-06 | 333 | 148 | 12 | int:PHLPP1 |
| Interaction | HECTD1 interactions | KRT18 CENPE PDHB MYO9B U2SURP UTP14A NCBP1 HEATR1 ZFC3H1 DCTN1 VIRMA EIF6 DDX18 EIF4G1 TPX2 TMPO ARHGEF2 GCN1 IQGAP3 WDR24 NSMCE4A | 1.07e-05 | 984 | 148 | 21 | int:HECTD1 |
| Interaction | NEFM interactions | 1.16e-05 | 190 | 148 | 9 | int:NEFM | |
| Interaction | YWHAE interactions | KIF21B KRT18 RASGRF1 CENPE PDHB MCFD2 ERC1 PPFIA1 NCBP1 DPP8 SHROOM2 DCTN1 VIRMA STXBP1 AKAP9 PIK3C2B AASS PIK3R1 CGN TMPO CGNL1 ARHGEF2 ACAP2 HOMER1 | 1.49e-05 | 1256 | 148 | 24 | int:YWHAE |
| Interaction | PTP4A3 interactions | 1.85e-05 | 154 | 148 | 8 | int:PTP4A3 | |
| Interaction | LRRC31 interactions | 2.12e-05 | 205 | 148 | 9 | int:LRRC31 | |
| Interaction | NYAP2 interactions | 2.22e-05 | 23 | 148 | 4 | int:NYAP2 | |
| Interaction | CAPZB interactions | TPM4 TBC1D15 MYH9 MYO6 PDHB MCFD2 ERC1 MTHFD1L PPFIA1 CD2AP NCBP1 DCTN1 VIRMA LIN7A EIF4G1 TMPO MTCL1 ARHGEF2 ACAP2 WDR24 MYBL2 | 2.76e-05 | 1049 | 148 | 21 | int:CAPZB |
| Interaction | NOLC1 interactions | ARGLU1 MYO10 CD2AP UTP14A VIRMA EAF1 AKAP9 PIK3R1 TMPO MME KIF11 | 2.91e-05 | 325 | 148 | 11 | int:NOLC1 |
| Interaction | SIRT7 interactions | MYH9 EPPK1 MTHFD1L U2SURP UTP14A NCBP1 ZNF318 LMNB2 HEATR1 VIRMA EIF6 MYH14 DDX18 CGN EIF4G1 GCN1 NUP160 | 3.40e-05 | 744 | 148 | 17 | int:SIRT7 |
| Interaction | YWHAH interactions | KIF21B EPPK1 KRT18 ERC1 PPFIA1 CD2AP DPP8 DCTN1 VIRMA FAM117A AKAP9 PIK3C2B AASS CGN MAD1L1 EIF4G1 MTCL1 CGNL1 ARHGEF2 HOMER1 KIF11 | 5.64e-05 | 1102 | 148 | 21 | int:YWHAH |
| Interaction | CCDC42 interactions | 6.13e-05 | 11 | 148 | 3 | int:CCDC42 | |
| Interaction | NIN interactions | KRT18 CENPE ERC1 UTP14A CCDC57 DCTN1 VIRMA EIF6 AASS CGNL1 ARHGEF2 | 7.14e-05 | 359 | 148 | 11 | int:NIN |
| Interaction | SCN2B interactions | 7.20e-05 | 95 | 148 | 6 | int:SCN2B | |
| Interaction | KCTD13 interactions | TPM4 MYH6 MYH9 CLIP2 MYO6 PDHB ARGLU1 ERC1 SYNE1 PPFIA1 PCLO DPYSL4 PPFIA3 SHROOM2 DCTN1 VIRMA STXBP1 MYH14 EIF4G1 TMPO CGNL1 ARHGEF2 HOMER1 DNAH11 | 7.90e-05 | 1394 | 148 | 24 | int:KCTD13 |
| Interaction | ARHGAP40 interactions | 8.56e-05 | 32 | 148 | 4 | int:ARHGAP40 | |
| Interaction | YWHAZ interactions | SYNPO2 MYH9 KRT18 RASGRF1 CLIP2 PDHB ERC1 PPFIA1 PPFIA3 DPP8 DCTN1 VIRMA PPP3CB PPP3CC AKAP9 PIK3C2B AASS PIK3R1 CGN CGNL1 ARHGEF2 HOMER1 KIF11 | 9.38e-05 | 1319 | 148 | 23 | int:YWHAZ |
| Interaction | CCDC8 interactions | TBC1D15 EPPK1 KRT18 MYO9B ZNF318 LMNB2 HEATR1 SMPDL3B CSGALNACT2 MYH14 CGN EIF4G1 TMPO ARHGEF2 GCN1 | 1.00e-04 | 656 | 148 | 15 | int:CCDC8 |
| Interaction | GAN interactions | 1.08e-04 | 253 | 148 | 9 | int:GAN | |
| Interaction | EED interactions | TPM4 TBC1D15 MYH9 KRT18 MYO6 ARGLU1 MTHFD1L UTP14A NCBP1 LMNB2 HEATR1 DCTN1 VIRMA EIF6 DDX18 CGN MAD1L1 EIF4G1 PALM3 TMPO CGNL1 NUP160 KIF11 MYBL2 | 1.37e-04 | 1445 | 148 | 24 | int:EED |
| Interaction | CD40 interactions | 1.39e-04 | 153 | 148 | 7 | int:CD40 | |
| Interaction | CEP72 interactions | 1.39e-04 | 107 | 148 | 6 | int:CEP72 | |
| Interaction | LGR4 interactions | 1.41e-04 | 262 | 148 | 9 | int:LGR4 | |
| Interaction | ANKRD50 interactions | 1.47e-04 | 108 | 148 | 6 | int:ANKRD50 | |
| Interaction | MYL6B interactions | 1.47e-04 | 108 | 148 | 6 | int:MYL6B | |
| Interaction | APEX1 interactions | TPM4 MYH9 GCFC2 CLIP2 MYO6 ERC1 PPFIA1 UTP14A HEATR1 YTHDC1 DCTN1 VIRMA NT5C AASS INTS13 MAD1L1 EIF4G1 TPX2 ARHGEF3 ACAP2 KIF11 TEDC1 | 1.50e-04 | 1271 | 148 | 22 | int:APEX1 |
| Interaction | FAM161A interactions | 1.56e-04 | 156 | 148 | 7 | int:FAM161A | |
| Interaction | GLUD1P3 interactions | 1.60e-04 | 3 | 148 | 2 | int:GLUD1P3 | |
| Interaction | CTDSPL2 interactions | 1.65e-04 | 70 | 148 | 5 | int:CTDSPL2 | |
| Interaction | CDC5L interactions | MYH9 EPPK1 KRT18 ARGLU1 SYNE1 PPFIA1 U2SURP UTP14A VIRMA AKAP9 MAD1L1 TPX2 TMPO MTCL1 ARHGEF2 GCN1 KIF11 | 1.85e-04 | 855 | 148 | 17 | int:CDC5L |
| Interaction | SEC13 interactions | 2.00e-04 | 216 | 148 | 8 | int:SEC13 | |
| Interaction | ADARB2 interactions | 2.45e-04 | 17 | 148 | 3 | int:ADARB2 | |
| Interaction | ERC2 interactions | 2.52e-04 | 42 | 148 | 4 | int:ERC2 | |
| Interaction | GRIN2B interactions | 2.65e-04 | 170 | 148 | 7 | int:GRIN2B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p13 | 1.16e-03 | 140 | 149 | 4 | chr2p13 | |
| Cytoband | 12q21.1 | 1.22e-03 | 16 | 149 | 2 | 12q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 1.24e-03 | 797 | 149 | 9 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q22 | 1.63e-03 | 71 | 149 | 3 | chr1q22 | |
| Cytoband | 9q34.1 | 1.73e-03 | 19 | 149 | 2 | 9q34.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q25 | 1.89e-03 | 160 | 149 | 4 | chr15q25 | |
| Cytoband | 11q13.3 | 2.32e-03 | 22 | 149 | 2 | 11q13.3 | |
| Cytoband | 2p13 | 2.53e-03 | 23 | 149 | 2 | 2p13 | |
| Cytoband | Xp22.3 | 2.53e-03 | 23 | 149 | 2 | Xp22.3 | |
| Cytoband | 1q21 | 3.30e-03 | 91 | 149 | 3 | 1q21 | |
| GeneFamily | Myosin heavy chains | 8.34e-09 | 15 | 91 | 5 | 1098 | |
| GeneFamily | Dyneins, axonemal | 7.97e-05 | 17 | 91 | 3 | 536 | |
| GeneFamily | Vesicle associated membrane proteins | 5.18e-04 | 7 | 91 | 2 | 12 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.60e-03 | 46 | 91 | 3 | 622 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 1.89e-03 | 13 | 91 | 2 | 693 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.52e-03 | 15 | 91 | 2 | 26 | |
| GeneFamily | Actins|Deafness associated genes | 2.55e-03 | 113 | 91 | 4 | 1152 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 4.05e-03 | 19 | 91 | 2 | 50 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.49e-03 | 66 | 91 | 3 | 722 | |
| GeneFamily | PDZ domain containing | 7.29e-03 | 152 | 91 | 4 | 1220 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | DOCK2 MYH9 CLIP2 CENPE MYO9B CD2AP SHROOM2 RALBP1 TPX2 ARHGEF3 ARHGEF2 KIF11 | 1.68e-09 | 199 | 149 | 12 | M5893 |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | DOCK2 MYH6 MCFD2 PPFIA1 CD2AP YTHDC1 PTPN11 PPP3CC PIK3C2B PLXNC1 ASMTL RALBP1 CDH8 NUP160 TPD52 DUSP11 | 2.81e-06 | 705 | 149 | 16 | M1410 |
| Coexpression | BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP | TPM4 KRT18 MCFD2 MYO10 CYP4B1 ANO1 FAM117A PIK3R1 TPX2 TMPO MX1 MX2 | 6.37e-06 | 427 | 149 | 12 | M17923 |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | TPM4 MYH9 MYO6 ADGRV1 TNFRSF21 TUFT1 PPP3CC PIK3C2B AASS CGN MTCL1 MME KYNU | 6.54e-06 | 504 | 149 | 13 | M2157 |
| Coexpression | DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 1.07e-05 | 242 | 149 | 9 | M34034 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | TPM4 KRT18 CENPE MYO10 ANO1 EIF6 FER1L6 MYH14 RALBP1 DDX18 EIF4G1 TPX2 | 1.29e-05 | 458 | 149 | 12 | M40010 |
| Coexpression | PEREZ_TP53_TARGETS | TPM4 EPPK1 MYO6 MYO10 DPYSL4 ADGRV1 SHROOM2 TUFT1 LIN7A EAF1 MMEL1 SMPDL3B AKAP9 ADAMTS7 TMCC2 MAD1L1 MTCL1 CGNL1 GOLGA6L9 MX1 | 1.61e-05 | 1201 | 149 | 20 | M4391 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | TPM4 CENPE MTHFD1L U2SURP NCBP1 CAMK2N2 RNF175 TUFT1 PTPN11 EIF4G1 TPX2 TMPO MME ACAP2 KIF11 | 1.63e-05 | 721 | 149 | 15 | M10237 |
| Coexpression | CROONQUIST_IL6_DEPRIVATION_DN | 1.75e-05 | 95 | 149 | 6 | M18506 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | URI1 CENPE MYO9B MYO10 ERC1 PPFIA1 U2SURP CD2AP PPP3CB AKAP9 MAD1L1 MTCL1 ACAP2 NUP160 HOMER1 KIF11 | 3.11e-05 | 856 | 149 | 16 | M4500 |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 3.44e-05 | 107 | 149 | 6 | MM947 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | DOCK2 DMTF1 KIF21B MYH9 URI1 MYO9B SYNE1 U2SURP B2M ZFC3H1 DPP8 YTHDC1 SBNO2 PTPN11 PPP3CB PPP3CC CSGALNACT2 AKAP9 PIK3R1 ARHGEF3 ACAP2 FMNL1 | 3.79e-05 | 1492 | 149 | 22 | M40023 |
| Coexpression | PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN | 3.82e-05 | 109 | 149 | 6 | M2451 | |
| Coexpression | WHITEFORD_PEDIATRIC_CANCER_MARKERS | 5.68e-05 | 117 | 149 | 6 | M7854 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 6.42e-05 | 236 | 149 | 8 | M130 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_TCONV_DN | 7.92e-05 | 180 | 149 | 7 | M2961 | |
| Coexpression | SHEPARD_CRASH_AND_BURN_MUTANT_DN | 1.15e-04 | 191 | 149 | 7 | M2148 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | ARGLU1 MYO10 NCBP1 PTPN11 EAF1 INTS13 PIK3R1 EIF4G1 CGNL1 MYBL2 | 1.20e-04 | 408 | 149 | 10 | M11891 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL | URI1 CD2AP HMBS LMNB2 PPP3CC TPX2 ARHGEF3 NUP160 MX1 KIF11 MYBL2 TEDC1 | 1.21e-04 | 578 | 149 | 12 | M45744 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | ARGLU1 MYO10 NCBP1 PTPN11 EAF1 INTS13 PIK3R1 EIF4G1 CGNL1 MYBL2 | 1.38e-04 | 415 | 149 | 10 | MM1028 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 1.48e-04 | 199 | 149 | 7 | M5235 | |
| Coexpression | GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP | 1.48e-04 | 199 | 149 | 7 | M6839 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN | 1.52e-04 | 200 | 149 | 7 | M7049 | |
| Coexpression | GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN | 1.52e-04 | 200 | 149 | 7 | M9539 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP | 1.52e-04 | 200 | 149 | 7 | M3785 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 1.52e-04 | 200 | 149 | 7 | M7529 | |
| Coexpression | HALLMARK_G2M_CHECKPOINT | 1.52e-04 | 200 | 149 | 7 | M5901 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN | 1.52e-04 | 200 | 149 | 7 | M9277 | |
| Coexpression | GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP | 1.52e-04 | 200 | 149 | 7 | M6982 | |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | MYO9B TNPO2 SYNE1 PPP3CB SMPDL3B CSGALNACT2 ADAMTS7 MYH14 PIK3R1 ARHGEF2 MYBL2 | 1.57e-04 | 506 | 149 | 11 | M253 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.83e-04 | 206 | 149 | 7 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.94e-04 | 208 | 149 | 7 | MM581 | |
| Coexpression | MENON_FETAL_KIDNEY_6_COLLECTING_DUCT_CELLS | 2.03e-04 | 94 | 149 | 5 | M39256 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 2.03e-04 | 94 | 149 | 5 | M18108 | |
| Coexpression | WANG_LMO4_TARGETS_DN | 2.32e-04 | 361 | 149 | 9 | M12674 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-08 | 194 | 150 | 9 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-08 | 194 | 150 | 9 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.40e-08 | 197 | 150 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.73e-08 | 200 | 150 | 9 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-07 | 169 | 150 | 8 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 171 | 150 | 8 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-07 | 171 | 150 | 8 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-07 | 174 | 150 | 8 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.53e-07 | 176 | 150 | 8 | 45c6983ab671b0f306e7390320bd84f848e474cc | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-07 | 184 | 150 | 8 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-07 | 190 | 150 | 8 | b65383e256b04122500b742caeed0b807793851e | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_T/NK-Cycling_Natural_Killer_Cell_/_Natural_Killer_T_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-07 | 190 | 150 | 8 | 89095d3e023269d89c82e3a73550f869e3f34201 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.22e-07 | 194 | 150 | 8 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.22e-07 | 194 | 150 | 8 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-07 | 196 | 150 | 8 | cb61757646653f89faba503cb5d99e5dd5197b4c | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 3.48e-07 | 196 | 150 | 8 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.48e-07 | 196 | 150 | 8 | 44e2df1b61e3819eae7e482bef0a733afe852d67 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.62e-07 | 197 | 150 | 8 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.76e-07 | 198 | 150 | 8 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.76e-07 | 198 | 150 | 8 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.76e-07 | 198 | 150 | 8 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.91e-07 | 199 | 150 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.91e-07 | 199 | 150 | 8 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.91e-07 | 199 | 150 | 8 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.97e-07 | 144 | 150 | 7 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-06 | 160 | 150 | 7 | 028b5261a1da832d52f66fb620db83e5fbbd874a | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-06 | 160 | 150 | 7 | 1f4ee446436726c3d373f56d87dd80b6a12e8b9e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-Unfolded_protein_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.70e-06 | 107 | 150 | 6 | 7fee0193ee02e9cc62f506660ea7ec23fb4d0c84 | |
| ToppCell | Dividing_Macrophages-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.75e-06 | 169 | 150 | 7 | eb0c993ef2eea73bc4881182520922ce9ae9368f | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 171 | 150 | 7 | ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-06 | 172 | 150 | 7 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 172 | 150 | 7 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | droplet-Spleen-SPLEEN-30m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 172 | 150 | 7 | 02cc4a9fb7902c572cee37ba828749db4913ee87 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-06 | 174 | 150 | 7 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-06 | 178 | 150 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 2.56e-06 | 179 | 150 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.56e-06 | 179 | 150 | 7 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.71e-06 | 65 | 150 | 5 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.71e-06 | 65 | 150 | 5 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-06 | 116 | 150 | 6 | a07f16917c66ce25f23ebef350d693cc4c324075 | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-06 | 181 | 150 | 7 | 0c5bc1660b8fc1e905ab4230202862de5be46ebd | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-06 | 181 | 150 | 7 | e482fd116c00ff4d8db7be3c06b1bd1ffa2d479d | |
| ToppCell | P15-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-06 | 181 | 150 | 7 | f83565f09dd971c5cad2704a4a86bca0accd955e | |
| ToppCell | P28-Endothelial-proliferative_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.75e-06 | 181 | 150 | 7 | 2be3d44619adb25d339e7a27b500a56e07e8de01 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-06 | 185 | 150 | 7 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 3.18e-06 | 185 | 150 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.29e-06 | 186 | 150 | 7 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 150 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-06 | 187 | 150 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 3.54e-06 | 188 | 150 | 7 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.66e-06 | 189 | 150 | 7 | fd8834d1feb7f63911c5fa51efb1f679a8baddeb | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.66e-06 | 189 | 150 | 7 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.66e-06 | 189 | 150 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.79e-06 | 190 | 150 | 7 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | 368C-Epithelial_cells|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.79e-06 | 190 | 150 | 7 | 459811e88d3001816c2d89034e0921c24918c17f | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.79e-06 | 190 | 150 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 3.92e-06 | 191 | 150 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Dividing_Macrophages-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.06e-06 | 192 | 150 | 7 | 741bd0c2b0a7ce3fcb1610ce8bdacaf9a803c212 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-06 | 194 | 150 | 7 | 1a2090e997c70433d07f56bf7cb0a50c4151118c | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 4.35e-06 | 194 | 150 | 7 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 195 | 150 | 7 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 195 | 150 | 7 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.50e-06 | 195 | 150 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 195 | 150 | 7 | 75759fd7f925725f0ecd07214afcca5aa2158f9e | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.50e-06 | 195 | 150 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 195 | 150 | 7 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 4.50e-06 | 195 | 150 | 7 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.50e-06 | 195 | 150 | 7 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_1|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.50e-06 | 195 | 150 | 7 | 47a01b8a92eebeb34ac7f70bf1ab4613a326e24f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.65e-06 | 196 | 150 | 7 | 35cc0986dc3fc4b89e960a565b8f9810b1688e09 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.81e-06 | 197 | 150 | 7 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-06 | 197 | 150 | 7 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.97e-06 | 198 | 150 | 7 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.97e-06 | 198 | 150 | 7 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 4.97e-06 | 198 | 150 | 7 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 5.14e-06 | 199 | 150 | 7 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.14e-06 | 199 | 150 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 5.14e-06 | 199 | 150 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 199 | 150 | 7 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.14e-06 | 199 | 150 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.14e-06 | 199 | 150 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 5.14e-06 | 199 | 150 | 7 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | Dividing_Macrophages|World / lung cells shred on cell class, cell subclass, sample id | 5.14e-06 | 199 | 150 | 7 | 5c755b6876e164dc847ef7c723f850f227cf3a87 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.31e-06 | 200 | 150 | 7 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.31e-06 | 200 | 150 | 7 | e3ad8d592686a5d1e1fb8dd05c2f00eac4c5738f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.31e-06 | 200 | 150 | 7 | 28c702449040ac15fe4e0c6340bb6f137e88539d | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-06 | 200 | 150 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | 5432bdf495431cd26f6e4cd585100f3652588913 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-06 | 200 | 150 | 7 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 5.31e-06 | 200 | 150 | 7 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-06 | 200 | 150 | 7 | 2afbb5b5742b956993796621fea7e0c9888754a1 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 5.31e-06 | 200 | 150 | 7 | 1cbb62df4ea1631fef8497e1702175605d0869e7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-06 | 200 | 150 | 7 | 4462ebd5d4632788f10a93fadd2babae701c754f | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 5.31e-06 | 200 | 150 | 7 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| Drug | purealin | 3.96e-12 | 58 | 148 | 10 | CID006419303 | |
| Drug | formycin triphosphate | 3.91e-11 | 51 | 148 | 9 | CID000122274 | |
| Drug | S-(-)-Etomoxir | 2.96e-07 | 100 | 148 | 8 | CID000060765 | |
| Drug | NSC339663 | MYH1 MYH6 MYH8 MYH9 MYO6 MYO9B MYO10 SYNE1 MYH14 PIK3R1 TPD52 | 7.64e-07 | 250 | 148 | 11 | CID000003892 |
| Drug | blebbistatin | 9.26e-07 | 116 | 148 | 8 | CID003476986 | |
| Drug | B0683 | 9.89e-07 | 117 | 148 | 8 | CID006398969 | |
| Drug | nocodazole | MYH1 MYH6 MYH8 MYH9 KRT18 MYO6 LMNB2 DCTN1 AKAP9 MYH14 MAD1L1 ARHGEF2 SLC4A5 KIF11 | 2.96e-06 | 477 | 148 | 14 | CID000004122 |
| Drug | clenbuterol | 4.24e-06 | 142 | 148 | 8 | CID000002783 | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.39e-06 | 199 | 148 | 9 | 6828_UP | |
| Drug | Biliton | 6.73e-06 | 41 | 148 | 5 | CID000002974 | |
| Drug | MgCl2 | 2.11e-05 | 354 | 148 | 11 | CID000024584 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 2.70e-05 | 183 | 148 | 8 | 7498_DN | |
| Drug | AC1L1IZ2 | 3.12e-05 | 304 | 148 | 10 | CID000004795 | |
| Drug | AC1NE2UB | 3.17e-05 | 56 | 148 | 5 | CID004635684 | |
| Drug | AC1NRBPQ | 3.23e-05 | 137 | 148 | 7 | CID005288569 | |
| Drug | NSC107658 | 3.30e-05 | 306 | 148 | 10 | CID000002919 | |
| Drug | resveratrol; Down 200; 50uM; MCF7; HG-U133A | 3.53e-05 | 190 | 148 | 8 | 622_DN | |
| Drug | AC1L9ITU | 3.68e-05 | 95 | 148 | 6 | CID000445947 | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.81e-05 | 192 | 148 | 8 | 7176_DN | |
| Drug | creatine | 3.95e-05 | 193 | 148 | 8 | CID000000586 | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 4.10e-05 | 194 | 148 | 8 | 6833_UP | |
| Drug | AC1Q5WMQ | 4.20e-05 | 2 | 148 | 2 | CID000134383 | |
| Drug | Ratjadone A, Synthetic | 4.20e-05 | 2 | 148 | 2 | CID000466014 | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; HL60; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 3085_DN | |
| Drug | candesartan cilexetil | 4.65e-05 | 145 | 148 | 7 | CID000002540 | |
| Drug | Nicergoline; Down 200; 8.2uM; MCF7; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 2220_DN | |
| Drug | sampatrilat | 7.34e-05 | 13 | 148 | 3 | CID006324648 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.30e-05 | 10 | 143 | 3 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.37e-05 | 12 | 143 | 3 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.37e-05 | 12 | 143 | 3 | DOID:2106 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.51e-05 | 71 | 143 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.08e-05 | 13 | 143 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 3.08e-05 | 13 | 143 | 3 | DOID:0112202 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 4.86e-05 | 15 | 143 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | total hip arthroplasty, osteoarthritis | 5.13e-05 | 42 | 143 | 4 | EFO_0009806, MONDO_0005178 | |
| Disease | focal segmental glomerulosclerosis (is_implicated_in) | 6.97e-05 | 3 | 143 | 2 | DOID:1312 (is_implicated_in) | |
| Disease | myopathy (implicated_via_orthology) | 8.72e-05 | 48 | 143 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 1.39e-04 | 4 | 143 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Kidney Failure | 1.60e-04 | 22 | 143 | 3 | C0035078 | |
| Disease | centronuclear myopathy 1 (implicated_via_orthology) | 2.31e-04 | 5 | 143 | 2 | DOID:0111223 (implicated_via_orthology) | |
| Disease | microcytic anemia (implicated_via_orthology) | 2.31e-04 | 5 | 143 | 2 | DOID:11252 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease dominant intermediate B (implicated_via_orthology) | 2.31e-04 | 5 | 143 | 2 | DOID:0110197 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | TPM4 MYH1 MYH9 HK3 KRT18 SYNE1 ZNF318 COLGALT2 SHROOM2 EIF6 THBS3 AKAP9 DDX18 MME DNAH9 | 2.35e-04 | 1074 | 143 | 15 | C0006142 |
| Disease | immature platelet fraction | 2.39e-04 | 114 | 143 | 5 | EFO_0009187 | |
| Disease | immature platelet measurement | 2.92e-04 | 119 | 143 | 5 | EFO_0803541 | |
| Disease | Hyalinosis, Segmental Glomerular | 3.34e-04 | 28 | 143 | 3 | C0086432 | |
| Disease | n-acetylserotonin O-methyltransferase-like protein measurement | 3.45e-04 | 6 | 143 | 2 | EFO_0801818 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 3.71e-04 | 29 | 143 | 3 | cv:C5779548 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 4.11e-04 | 30 | 143 | 3 | C1868672 | |
| Disease | protein FAM3B measurement | 4.82e-04 | 7 | 143 | 2 | EFO_0021857 | |
| Disease | able to hear with hearing aids | 4.82e-04 | 7 | 143 | 2 | EFO_0009720 | |
| Disease | Nonsyndromic genetic hearing loss | 5.18e-04 | 76 | 143 | 4 | cv:C5680182 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 5.47e-04 | 33 | 143 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | reticulocyte count | MYH9 MYO9B U2SURP CD2AP EIF6 SBNO2 PTPN11 PIK3R1 TMCC2 DNAH17 PALM3 ARHGEF3 ACAP2 MYBL2 | 5.76e-04 | 1045 | 143 | 14 | EFO_0007986 |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.29e-04 | 80 | 143 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | twisted gastrulation protein homolog 1 measurement | 6.41e-04 | 8 | 143 | 2 | EFO_0803205 | |
| Disease | Nonsyndromic Deafness | 6.59e-04 | 81 | 143 | 4 | C3711374 | |
| Disease | Focal glomerulosclerosis | 7.08e-04 | 36 | 143 | 3 | C0017668 | |
| Disease | Hereditary hearing loss and deafness | 7.44e-04 | 146 | 143 | 5 | cv:C0236038 | |
| Disease | Inherited focal segmental glomerulosclerosis | 1.02e-03 | 10 | 143 | 2 | cv:CN327126 | |
| Disease | diabetes mellitus biomarker | 1.02e-03 | 10 | 143 | 2 | EFO_0006842 | |
| Disease | Focal segmental glomerulosclerosis | 1.02e-03 | 10 | 143 | 2 | cv:C0017668 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 1.25e-03 | 11 | 143 | 2 | cv:CN043612 | |
| Disease | mean platelet volume | TPM4 MYH9 PDHB MYO9B U2SURP CD2AP UTP14A TNFRSF21 TMCC2 ARHGEF3 VAMP4 ACAP2 KYNU | 1.42e-03 | 1020 | 143 | 13 | EFO_0004584 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.49e-03 | 12 | 143 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 1.76e-03 | 13 | 143 | 2 | cv:C4273714 | |
| Disease | immature platelet count | 1.79e-03 | 106 | 143 | 4 | EFO_0803544 | |
| Disease | mean reticulocyte volume | MYH9 MYO9B MCFD2 ZNF318 DPP8 SBNO2 PTPN11 FAM117A PIK3R1 TMCC2 TPX2 | 1.82e-03 | 799 | 143 | 11 | EFO_0010701 |
| Disease | reticulocyte measurement | MYH9 MYO9B U2SURP EIF6 SBNO2 PIK3R1 TMCC2 DNAH17 EIF4G1 TPX2 ARHGEF3 ACAP2 MYBL2 | 1.88e-03 | 1053 | 143 | 13 | EFO_0010700 |
| Disease | basal cell carcinoma | 2.33e-03 | 189 | 143 | 5 | EFO_0004193 | |
| Disease | Dyskinesia, Medication-Induced | 2.35e-03 | 15 | 143 | 2 | C0751088 | |
| Disease | Dyskinesia, Drug-Induced | 2.35e-03 | 15 | 143 | 2 | C0013386 | |
| Disease | platelet crit | TPM4 MYO9B MCFD2 U2SURP TRPC6 ZNF318 ADGRV1 EIF6 MAD1L1 ARHGEF3 NUP160 WDR24 | 2.37e-03 | 952 | 143 | 12 | EFO_0007985 |
| Disease | lean body mass | 2.57e-03 | 379 | 143 | 7 | EFO_0004995 | |
| Disease | Hypertrophic Cardiomyopathy | 2.69e-03 | 57 | 143 | 3 | C0007194 | |
| Disease | cutaneous melanoma | 2.90e-03 | 121 | 143 | 4 | EFO_0000389 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.12e-03 | 60 | 143 | 3 | C4722327 | |
| Disease | hypertension (implicated_via_orthology) | 3.55e-03 | 128 | 143 | 4 | DOID:10763 (implicated_via_orthology) | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 3.78e-03 | 19 | 143 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | platelet measurement | 4.45e-03 | 315 | 143 | 6 | EFO_0005036 | |
| Disease | Prostate cancer, familial | 4.62e-03 | 69 | 143 | 3 | C2931456 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KIEEELEALFLEREV | 176 | Q8N6Q1 | |
| EVDLLKNGERIEKVE | 56 | P61769 | |
| ERERVLLEELEALKQ | 1651 | Q99996 | |
| VKDLLLEDLQDGEVR | 381 | Q9NR81 | |
| REEEEEELLSGKINR | 356 | Q96L12 | |
| EEEGLRAQVRDLEEK | 216 | Q14203 | |
| EEKVRELRETVGDLE | 451 | Q14203 | |
| GEEKVVERELDALLE | 51 | Q9H9E3 | |
| QDAIREVEGLKDLLV | 656 | Q92974 | |
| IEEKLIEEETARRVE | 121 | Q9NWB6 | |
| VKEQGEEELLRILDI | 226 | Q9C073 | |
| GLLDEILKQEIRLID | 121 | Q9UDR5 | |
| TVEEEDGEIRLLVIR | 1731 | Q8WXG9 | |
| EDLLRGEIEESLEKV | 406 | Q96DT5 | |
| LQLEEELTLRRGEIE | 506 | Q9UDT6 | |
| LKQDFGVVRELLEEE | 606 | Q17RM4 | |
| KLEQLSEEVLAIRGE | 936 | Q8N283 | |
| ELELKVGDIIDINEE | 126 | Q9Y5K6 | |
| LEEVEGDVAELELKL | 21 | Q15057 | |
| VLAKEIGLLADEIEI | 376 | Q6UB35 | |
| KEDEINLILRIAELD | 341 | Q9Y222 | |
| DDIKRELRAEVDIIE | 171 | Q96JC9 | |
| VRLILLEEEEQGLKI | 296 | P58397 | |
| IVRLVLLEDEEEDLK | 291 | Q9UKP4 | |
| KEEIERLRAEIAEIQ | 511 | Q15311 | |
| AEVDRLLEILKEVEN | 756 | Q8IUD2 | |
| VVLGDLLIDDKDTVR | 136 | Q8TCD5 | |
| EEANILGRKIVELEV | 576 | Q9Y4B5 | |
| ILERGKEELAEAEII | 606 | Q9NVM9 | |
| EAKVEEVVLEAIGDR | 241 | A6NDB9 | |
| KDIIIDLGEIRERAL | 136 | Q7RTW8 | |
| EEVEIEREVLLEKFI | 191 | Q9H3L0 | |
| ELERDEKVFLLGEEV | 46 | P11177 | |
| RLQLETEIEALKEEL | 196 | P05783 | |
| QEEEEKARLLIGLSV | 2206 | Q14667 | |
| RAIELLEKLQESGEV | 31 | O14910 | |
| EEADTLRLKVEELEG | 496 | Q9Y6D9 | |
| SDRKDGVLEEQIERL | 681 | Q09161 | |
| GVLEEQIERLQEKVE | 686 | Q09161 | |
| ELINIIDGVLRDDDK | 116 | Q8NI22 | |
| ELIEKIGAVEEELNR | 421 | P52732 | |
| RLQIEIGKLRAELDE | 116 | Q03252 | |
| LLEREEEIAELKAER | 96 | O75145 | |
| EKLGEAAVLEIVERL | 101 | Q92485 | |
| GLLLVETLLDEEKRV | 551 | O95671 | |
| EERKLLRIIAEADGE | 581 | Q5T655 | |
| EELRAQLGRKEEELQ | 1096 | Q7Z406 | |
| IKELQARIEELGEEI | 1111 | P13535 | |
| QKLEARVRELEGEVE | 1816 | P13535 | |
| KILQDIDRELDLVER | 3761 | Q9Y6V0 | |
| LELLESELRKEIRDG | 981 | O60486 | |
| EEKGLQELAEEIEVL | 971 | O75037 | |
| RDELEVVLKDVLQEP | 111 | P08473 | |
| ETRTLEIEILGALEK | 596 | Q8N3D4 | |
| QVEEILRLEKEIEDL | 886 | Q9HD67 | |
| REQLLEREEEIAELK | 101 | Q13136 | |
| ERERLLEEVEKLLEQ | 361 | A6NEY3 | |
| GQERLLEEVEKLLEQ | 321 | A6NEF3 | |
| ERLLEEVEKLLEQER | 246 | A6NEM1 | |
| GQERLLEEVEKLLEQ | 356 | H0YKK7 | |
| LIEELHKEIRLIGNE | 2231 | Q92616 | |
| VGEKTEERRVERDIL | 331 | P42167 | |
| RELDVDGIIAEIKAQ | 281 | Q9NSB4 | |
| IQKLEARVRELEGEV | 1816 | P12882 | |
| LKEEVGEEAIVELVE | 46 | P35579 | |
| LEEERDLKITDVIIG | 771 | P35579 | |
| LEAGLELERDEDTKI | 136 | Q5XXA6 | |
| VIDILIDIIREKGVD | 471 | Q06124 | |
| KEREEDIDLHLGDIL | 16 | P27986 | |
| DRILDVGFEEELKQI | 336 | Q9NVP1 | |
| VLRDELEVILKAVLE | 141 | Q495T6 | |
| AVVEKIRENRGLEEL | 846 | P52790 | |
| EVEKELDVLQGRVAE | 266 | O95502 | |
| EILDGKIFELTELRD | 331 | Q86YM7 | |
| AQELGLVELLEKEEV | 346 | Q86VI3 | |
| KLLEHRILEEEEVLG | 201 | O00750 | |
| LDRETEEILADVLKV | 121 | P56537 | |
| TGDLLINEKLDREEL | 81 | Q9NRJ7 | |
| NGDIVEEEQKRLLEL | 201 | O14531 | |
| KRDELVEVIEAGLEV | 176 | Q8N6G5 | |
| IELLVGVDINEDKLR | 71 | Q5T8I9 | |
| EGALLILLDKETDER | 1126 | Q86XA9 | |
| NKILELDLIVRDEDG | 156 | Q92608 | |
| KIREQNEELGLIIDL | 126 | O75319 | |
| EEVLKGLQGEIEEVL | 356 | Q9UFH2 | |
| EFRDEVEEIILILVK | 741 | P16383 | |
| RLEESEGELRKNLEE | 671 | Q0VF96 | |
| EDREKGALIEELLQA | 721 | Q0VF96 | |
| IERLLEEEAVKEFIE | 826 | Q5T1B0 | |
| DAEGRIIDVIDKELI | 351 | Q6V1X1 | |
| LERKLEELDGELALQ | 156 | Q2TAC2 | |
| ESELEVLEILKLREE | 691 | Q8IY82 | |
| LAIDTEERLKGVIDL | 786 | Q04637 | |
| LELKVEELEEKGLIR | 476 | O95466 | |
| LDILLGARDEDDIKL | 286 | P13584 | |
| EILKGLEERLLETVL | 1541 | Q9H583 | |
| VKALLEEILERVTDE | 4221 | Q9NYC9 | |
| PLIIKDDEDVRENII | 651 | P55286 | |
| GVEVRAKDQDILDLV | 221 | P08397 | |
| DRELEKTLVIEDDVR | 426 | Q8IYK4 | |
| KEGRVDEEIALRIIN | 61 | P16298 | |
| IENQEELRLLGDELK | 1081 | Q02224 | |
| IDVLLLARDEDGKEL | 306 | Q6NT55 | |
| FLEESIEEVRELIKI | 606 | Q2WGJ9 | |
| QREKRELEGVILELQ | 301 | Q59EK9 | |
| EIDSKILERLLEELQ | 681 | Q5TCS8 | |
| ELERQEELLGELDSK | 216 | O94763 | |
| ITKVIERGERLDELQ | 71 | O75379 | |
| ELRVIEEIPQAEDKL | 611 | O75509 | |
| LDALLEELREIKEGQ | 516 | O75069 | |
| VREKGEALLELVQDV | 3876 | Q8NF91 | |
| LKKRLDGIEEVEREI | 596 | Q7Z7B0 | |
| DLEDIEGLTVRQLKE | 246 | Q8WZ73 | |
| LEEDLKEVLRSEAGI | 541 | P10244 | |
| KEVLRSEAGIELIIE | 546 | P10244 | |
| DVGLVNEELRERLLK | 1956 | P58107 | |
| VEDLKSEELAREIVG | 1311 | Q13796 | |
| IIEQRELEDKIHLGE | 1586 | Q13796 | |
| GVLERVERLKQDLLD | 706 | Q9Y2G9 | |
| DLRLETGKEIIIEER | 286 | Q9BV20 | |
| EATEKEVERILGLLQ | 261 | Q9NXX6 | |
| KLEARVRELEGELEA | 1816 | P13533 | |
| IGEARVKEVLLDEDD | 271 | P61764 | |
| EVGKEEFLDRLIRSE | 936 | Q12769 | |
| RQQIEDGEIEIERLK | 161 | Q13972 | |
| EEQRDKLEEILRGLT | 536 | O15042 | |
| EILEGERGKEITELL | 156 | Q8NEL0 | |
| ETRELLEEVLEGKQR | 471 | Q9P2M7 | |
| LEEVLEGKQRVEEQL | 476 | Q9P2M7 | |
| EELGEKIEVLQRELE | 601 | Q9P2M7 | |
| RVVIEDDRIDDVLKG | 56 | Q96S95 | |
| ILTELREEGKALNEE | 221 | Q86WT6 | |
| LVKEGRLEEEVALKI | 46 | P48454 | |
| LLAKVREGEVALEEL | 246 | Q9NNX1 | |
| RKLVILEGELERAEE | 131 | P67936 | |
| GRVAEELILREKVEA | 176 | Q9UMS6 | |
| IDQLQLRVLKEGDEE | 236 | Q8N7C7 | |
| LRVLKEGDEELDLNE | 241 | Q8N7C7 | |
| EEANILGRKIVELEV | 596 | Q5TF21 | |
| VELEVENRGLKAELD | 606 | Q5TF21 | |
| GQKIIVELDEEGLIE | 231 | Q8N4F7 | |
| IDIILLKGDVEEDEA | 311 | O14787 | |
| GELDLVVRELQALEE | 356 | Q86SX3 | |
| IIDDVIEKQIEDGLL | 186 | Q9BY07 | |
| LTLEEAIEKQRLLEE | 206 | Q13084 | |
| ERVQTLEELEELGKE | 506 | Q9BVJ6 | |
| GILRVLEKDAEVIVD | 36 | Q8TC07 | |
| ILVELRDDIRDQVKE | 241 | P49746 | |
| GERLELLIDKTENLV | 151 | P51809 | |
| REEKDGELNVLDDIL | 6 | Q96MU7 | |
| DEGLLIVKIEEEEFI | 16 | P49910 | |
| TEDLAELIRELGEKL | 906 | Q9Y210 | |
| VLIVLGERVRKDIDE | 656 | Q96S15 | |
| QEELRRELAKVEEEI | 76 | P55327 | |
| EGEIERLINLLEEVF | 621 | Q69YN4 | |
| KLGEDEEELSELQLR | 361 | O60293 | |
| LKERVKELSEGIVDE | 1781 | Q5VUA4 | |
| LELDVADIKIVEERR | 436 | O43156 | |
| IGFDLEIEKRIQERE | 431 | Q9ULW0 | |
| EETLRIEDILEVIEK | 196 | Q16719 | |
| IEDIRAEQEREGEKL | 506 | P20591 | |
| QDIEKLVEGEEVVRE | 431 | P20592 | |
| DLIEAKLVGILDILD | 516 | Q9UM54 | |
| KLVGILDILDEENRL | 521 | Q9UM54 | |
| GGDEDREKEILIERI | 1956 | Q13459 |